Compositions containing a non-caffeine stimulant or nootropic and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

A synergistic composition comprising:

• a non-caffeine stimulant or nootropic selected from the group consisting of paraxanthine, methylliberine, theacrine, theobromine, dopamine promoter, dopamine precursor, dopamine receptor agonist, dopamine breakdown or reuptake inhibitor, acetylcholine promoter, acetylcholine precursor, acetylcholine receptor agonist, acetylcholinesterase inhibitor, acetylcholine reuptake inhibitor, serotonin promoter, and cyclic adenosine monophosphate (cAMP) modulator;
• and
• at least one ketone body or ketone body precursor selected from the group consisting of beta-hydroxybutyrate (BHB) salt, BHB ester, beta-hydroxybutyric acid, 1,3-butanediol, and combinations thereof,
• wherein a ratio of the at least one ketone body or ketone body precursor to the non-caffeine stimulant or nootropic is at least about 10:1.

A synergistic composition comprising:

• a non-caffeine stimulant or nootropic selected from the group consisting of paraxanthine, methylliberine, theacrine, theobromine, dopamine promoter, dopamine precursor, dopamine receptor agonist, dopamine breakdown or reuptake inhibitor, acetylcholine promoter, acetylcholine precursor, acetylcholine receptor agonist, acetylcholinesterase inhibitor, acetylcholine reuptake inhibitor, serotonin promoter, and cyclic adenosine monophosphate (cAMP) modulator;
• at least one ketone body or ketone body precursor selected from the group consisting of beta-hydroxybutyrate (BHB) salt, BHB ester, beta-hydroxybutyric acid, 1,3-butanediol, and combinations thereof;
• and
• a pharmaceutically or dietetically acceptable carrier,
• wherein a ratio of the at least one ketone body or ketone body precursor to the non-caffeine stimulant or nootropic is at least about 10:1,
• wherein the composition is provided in solid, powder, or liquid form.